Rudi Mao

Prognostic value of baseline serum lactate dehydrogenase in EGFR-mutant lung adenocarcinoma treated with first-line EGFR-TKI monotherapy

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are standard first-line treatment for patients with sensitizing EGFR-mutant lung adenocarcinoma; however, treatment outcomes remain heterogeneous and acquired resistance eventually develops in most patients...